文献速递肝胆胰外科围术期管理与 ERAS

胰切除术后糖耐量变化:胰十二指肠切除术与远端胰腺切除术的前瞻性观察随访研究

Glucose Tolerance after Pancreatectomy: A Prospective Observational Follow-Up Study of Pancreaticoduodenectomy and Distal Pancreatectomy.
PubMed 文献 · J Am Coll Surg · 2021-09-13

这项前瞻性单中心观察研究纳入40例胰十二指肠切除术(PD)和29例远端胰腺切除术(DP)患者,用口服葡萄糖耐量试验和胰高血糖素刺激试验评估术前及术后1个月糖耐量、胰岛素分泌与胰岛素抵抗,并随访3年HbA1c。结果显示PD后糖耐量改善而DP后恶化,两者胰岛素分泌均下降,PD后胰岛素抵抗改善而DP后无变化,但糖耐量分类变化及长期HbA1c差异均无统计学意义。

要点

  • PD后糖耐量改善而DP后恶化,但变化均未达统计学显著。
  • PD和DP后胰岛素分泌(ΔCPR)均显著下降。
  • PD后胰岛素抵抗(HOMA-IR)改善,DP后无变化。

核心结论

  • 比较术前与术后1个月数据,PD后糖耐量改善,而DP后糖耐量恶化。
  • PD和DP后胰岛素分泌均下降;PD后胰岛素抵抗改善,DP后无变化。
  • DP后HbA1c中位数在长达3年内高于PD后,但差异无统计学意义。

研究设计与样本

  • 前瞻性单中心观察研究,分析40例接受PD和29例接受DP的患者(临床试验注册号UMIN000008122)。
  • 术前及术后1个月用口服葡萄糖耐量试验和胰高血糖素刺激试验评估糖耐量、胰岛素分泌(ΔCPR)和胰岛素抵抗(HOMA-IR)。
  • 随访3年评估患者长期HbA1c水平。

主要发现

  • 诊断为异常OGTT的患者比例PD后从12/40(30%)降至7/40(17.5%),p=0.096。
  • 诊断为异常OGTT的患者比例DP后从4/29(13.8%)升至8/29(27.6%),p=0.103。
  • ΔCPR在PD后从3.2降至1.0 ng/mL(p<0.001),在DP后从3.3降至1.8 ng/mL(p<0.001)。
  • HOMA-IR在PD后从1.10降至0.68(p<0.001),在DP后从1.10变为1.07(p=0.42)。
  • DP后HbA1c中位数在长达3年内高于PD后,但差异无统计学意义。

临床怎么用

  • PD与DP对术后糖耐量的影响不同,术后血糖管理策略可据此个体化考虑。
  • PD和DP后均需关注胰岛素分泌下降,监测糖代谢变化。
  • DP后糖耐量可能恶化,应加强术后糖代谢随访。

局限性

  • 单中心观察研究,样本量较小(PD 40例,DP 29例)。
  • 糖耐量分类变化及长期HbA1c差异均无统计学意义。
  • PD后胰岛素抵抗改善的机制尚待进一步研究阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Effects of pancreatectomy on glucose tolerance have not been clarified, and evidence regarding the difference in postoperative glucose tolerance between pancreaticoduodenectomy (PD) and distal pancreatectomy (DP) is lacking. STUDY DESIGN: This prospective, single-center observational study analyzed 40 patients undergoing PD and 29 patients undergoing DP (Clinical trial registry number UMIN000008122). Glucose tolerance, including insulin secretion (Δ C-peptide immunoreactivity, ΔCPR) and insulin resistance (homeostasis model assessment of insulin resistance, HOMA-IR) were assessed before and 1 month after pancreatectomy using the oral glucose tolerance test (OGTT) and glucagon stimulation test. We assessed long-term hemoglobin A1c (HbA1c) levels in patients, with a follow-up time of 3 years. RESULTS: Percentages of patients diagnosed with abnormal OGTT decreased after PD (from 12 [30%] to 7 [17.5%] of 40 patients, p = 0.096); however, they increased after DP (from 4 [13.8%] to 8 [27.6%] of 29 patients, p = 0.103), although the changes were not statistically significant. ΔCPR decreased after both PD (from 3.2 to 1.0 ng/mL, p < 0.001) and DP (from 3.3 to 1.8 ng/mL, p < 0.001). HOMA-IR decreased after PD (from 1.10 to 0.68, p < 0.001), but did not change after DP (1.10 and 1.07, p = 0.42). Median HbA1c level was higher after DP than after PD for up to 3 years, but the differences were not statistically significant. CONCLUSIONS: In comparisons of pre- and 1 month post-pancreatectomy data, glucose tolerance showed improvement after PD, whereas it worsened after DP. Insulin secretion decreased after both PD and DP. Insulin resistance improved after PD, but did not change after DP. Further studies are warranted to clarify mechanisms of improved insulin resistance after PD.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Ishida J, Toyama H, Matsumoto I, et al. Glucose Tolerance after Pancreatectomy: A Prospective Observational Follow-Up Study of Pancreaticoduodenectomy and Distal Pancreatectomy. J Am Coll Surg. 2021. PMID: 34530126. doi:10.1016/j.jamcollsurg.2021.08.688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。